ResMed Inc. (FRA:RME)

Germany flag Germany · Delayed Price · Currency is EUR
227.90
-2.30 (-1.00%)
Last updated: Sep 26, 2025, 8:15 AM CET
-1.00%
Market Cap33.71B
Revenue (ttm)4.38B
Net Income (ttm)1.19B
Shares Outn/a
EPS (ttm)8.10
PE Ratio28.27
Forward PE24.79
Dividend1.98 (0.87%)
Ex-Dividend DateAug 14, 2025
Volume20
Average Volume9
Open227.90
Previous Close230.20
Day's Range227.90 - 227.90
52-Week Range180.20 - 250.20
Betan/a
RSI42.49
Earnings DateOct 23, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1989
Employees 10,600
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol RME
Full Company Profile

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD Financial Statements

News

There is no news available yet.